000 01389 a2200373 4500
005 20250516105315.0
264 0 _c20120926
008 201209s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD000494.pub4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTunçalp, Özge
245 0 0 _aProstaglandins for preventing postpartum haemorrhage.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cAug 2012
300 _aCD000494 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aAdministration, Oral
650 0 4 _aAdministration, Sublingual
650 0 4 _aFemale
650 0 4 _aFever
_xchemically induced
650 0 4 _aHumans
650 0 4 _aLabor Stage, Third
650 0 4 _aMisoprostol
_xadverse effects
650 0 4 _aOxytocics
_xadverse effects
650 0 4 _aPostpartum Hemorrhage
_xprevention & control
650 0 4 _aPregnancy
650 0 4 _aProstaglandins
_xtherapeutic use
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aShivering
700 1 _aHofmeyr, G Justus
700 1 _aGülmezoglu, A Metin
773 0 _tThe Cochrane database of systematic reviews
_gno. 8
_gp. CD000494
856 4 0 _uhttps://doi.org/10.1002/14651858.CD000494.pub4
_zAvailable from publisher's website
999 _c22027638
_d22027638